We found that CTNNA1 and CTNNA2 had higher expressions, while CTNNA3 had consistently lower expression in both Wolf and Seeger datasets from patients with neuroblastoma (Figure 1A and 1B). This evidence concerns the gene CTNNA2 and neuroblastoma.